WINT
Windtree Therapeutics Inc
Mentions (24Hr)
600.00% Today
Reddit Posts
Windtree (WINT) Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
Dog Days of Summer, except ...$DSS, $OLB, $SILO, $WINT
Summertime Trading Under the Radar: $DSS, $OLB, $WINT
Summertime Trading Under the Radar: $DSS, $OLB, $WINT
$WINT MarketWatch shows 68% SI and 170k float… CTB 680%
WINT Chances of a resurge? Was 4/14 a squeeze?
Windtree therapeutics or wint has great potential and high CTB
Feetr Data Dump: "Bed Bath stock" CJJD WINT ALLR LUNR
$WINT 1 Stock 2 Alerts 🚨- Great Job Bulls - Looking Forward To More Incredible Action This Week 🔥
WINT Revival (Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office)
Anyones take on $WINT? Bearish and/or Bullish accepted TY
Anyone have time to look into WINT??? Looks like it found bottom any chance for a spike?
💰💰💰Good morning! #premarket #watchlist 09/29 $WINT - Announces Positive Istaroxime Phase 2 Study in Early Cardiogenic Shock (SEISMiC), $BBAI -Awarded $14.8 Million U.S. Army Global Force Information Management System Contract, $AXLA -Positive Interim Data from Phase 2b EMMPACT Study of AXA1125
💰💰💰Good morning! #premarket #watchlist 09/29 $WINT - Announces Positive Istaroxime Phase 2 Study in Early Cardiogenic Shock (SEISMiC), $BBAI -Awarded $14.8 Million U.S. Army Global Force Information Management System Contract, $AXLA -Positive Interim Data from Phase 2b EMMPACT Study of AXA1125
💰💰💰Good morning! #premarket #watchlist 09/29 $WINT - Announces Positive Istaroxime Phase 2 Study in Early Cardiogenic Shock (SEISMiC), $BBAI -Awarded $14.8 Million U.S. Army Global Force Information Management System Contract, $AXLA -Positive Interim Data from Phase 2b EMMPACT Study of AXA1125
WINT 🎯Windtree may receive up to $78.9 million in development, regulatory and commercial milestones plus low double digit royalties Development and all other costs to be assumed by Lee’s Pharmaceutical and Zhaoke Pharmaceutical
💰💰💰Good morning! #premarket #watchlist 08/23 $WINT -Announces KL4 Surfactant and AEROSURF® Global License Agreement, $MRIN -Announces Snapchat Integration, $AERI -Surges as Alcon to Buy Eye Care Firm in $770 Million Deal, $ILAG -lowfloat stock+china
💰💰💰Good morning! #premarket #watchlist 08/23 $WINT -Announces KL4 Surfactant and AEROSURF® Global License Agreement, $MRIN -Announces Snapchat Integration, $AERI -Surges as Alcon to Buy Eye Care Firm in $770 Million Deal, $ILAG -lowfloat stock+china
💰💰💰Good morning! #premarket #watchlist 08/23 $WINT -Announces KL4 Surfactant and AEROSURF® Global License Agreement, $MRIN -Announces Snapchat Integration, $AERI -Surges as Alcon to Buy Eye Care Firm in $770 Million Deal, $ILAG -lowfloat stock+china
Good morning! 🌞 #premarket #watchlist 04/20 $IO -awarded five-year contract with Brunei Shell Petroleum, $WINT -Positive Topline Results from Its Phase 2, $ALVR -FDA Grants Regenerative Medicine Therapy, $CRXT - meeting April 21-23 ... Also check afterhours runners and low float stocks in my app!
#premarket 08/09 $BTCM $WINT $SIC $FTFT $BITF
What about $NAKD stock and WINT $STOCK...
[WINT] High Volume Low Float, Offering Swing Play
WINT - Windtree Therapeutics Inc Forecast - CNNMoney.com - target price of $12.25 currently at $2.52. 386% potential gain.
Potential SWING TRADE: $WINT drops nearly 30% on public offering, hit 52 week low and currently trading UNDER offering price! New users, pay attention
Mentions
LPSN WINT thoughts? Buy zone?
Good stuff! For the others if you’re not already in, don’t chase $WINT or $TRNR unless a new setup forms. Instead, track setups like $HSDT. Finviz.com
lol you CAN NOT have timed WINT any better…well done Congrats on the profit
OK Repair, I saw your post on WINT and didn't take a look. My mistake. Could have gotten in at .73 at that point. Good call on your point.
Bullish on WINT — Dril baby Dril
WINT volume coming in after news. Technicals look good
Any expected catalysts for WINT or CDLI?
**GNPX** At 90D support level near 52w low as of today, may bounce tomorrow *but could continue down* **MBRX** Offering closed, should recover some tomorrow with the 1 year cash runway at current burn rate **MSAI** Nothing special here but looks like it might dip some further and rebound tomorrow. Decent company with high insider and institutional ownership. **WINT** Possible small recovery but likely will continue down **LCTX** Long on this one, looking like the FDA will ease up given the reduction in risk. It's been climbing.
WINT just also apparently purchased a fucking waste management company. Why is a therapeutics company now in waste management? It's such an odd conglomeration.
Keep an eye on WINT. It just released good news. [Windtree Receives Offer for Its Preclinical Oncology Drug](https://www.globenewswire.com/news-release/2025/06/11/3097588/0/en/Windtree-Receives-Offer-for-Its-Preclinical-Oncology-Drug-Candidate.html)
Yo fellas real talk is WINT Calls crazy?
What is going on with WINT? On the move up!
Man, I see so many roundtrips premarket it makes me hesitate on early pullbacks on momentum stocks. Didn't buy WINT under a dollar before it ripped to 1.5 and just now didn't get in CARM under 0.6 before it ripped to 0.8. Ended up chasing both for smaller scalps.
WINT going strong now that I got out
WINT scammed me I got in and died :P <3 my own fault I had a feeling it was just a pdiddy
Did you have it all in WINT? That reverse split fckd me up the a
WINT has great potential Low market cap and dropped big at opening. Way oversold! They had good news and I can see it rebound to 3$ again today. Currently trading at 2.20$ 
WINT Great opportunity
Christ, I hope everyone got out of WINT alive...
WINT dead? I fucked up with that one, i know
Is WINT still on the radar?
WINT has good volume and a high mark cap ... I'm sensing a move.
Don't ask me for DD cuz I didn't really do it, but I'm in INAB and WINT. Idk, they had good news 🤷♀️
Anyone here have WINT? They had a positive phase 2 yesterday.. onto phase 3… just got in a lil yesterday
Same. Not a huge loss but it happens. Killed it last week and Monday on CYN, MGOL and OCEA. Couldn't have timed the entries and exits any better. Then gave it all back on NXU, ADTX, WINT and some stupid thing I bought AH. They literally tanked as soon as I bought them. Penny stocks are literally a lotto play. Don't beat yourself up about it. The pump and dumps are rabid right now. Logic is out the window on what is making money. I haven't sold, hoping my bags recover enough to minimize losses. I am going to slow down and stop being so impulsive with my buy ins.
Damn that was on my scanner this a.m but I put my money in WINT and bought too high 
Split usually = good. It’s usually done to lower the price of a stock to be more appealing to investors. Reverse split usually = bad. I’ve seen a few companies rip right before one but idk why. It usually means the company’s gonna be delisted because the share price isn’t high enough. Then you have shit like BRKA which has never split and is like $600,000+ per share or whatever it is now. WINT might be worth looking into after the RS.
Obviously, AH doesn't like it, but I am interested in seeing where WINT goes the next couple of days. Steady growth in volume the last couple of days. According to Fintel, short shares dried up this morning.
Holding WINT, SPGC, HIVE, ELTP, and ADTX rn. Almost convinced WINT and especially ADTX were flukes. Any thoughts on these now?
WINT KEEEEEPS going down. Do I dump?
As of February 12, 2025, Windtree Therapeutics, Inc. (NASDAQ: WINT) has not announced any recent plans for a reverse stock split. The most recent reverse stock split occurred on April 19, 2024, when the company implemented a 1-for-18 reverse split to increase the market price per share and comply with Nasdaq’s listing requirements.  Currently, WINT is trading at $0.174 per share, with an intraday high of $0.2882 and a low of $0.1639. Given the current share price, which is below Nasdaq’s minimum bid price requirement of $1.00, the company may consider future actions to regain compliance. However, as of now, no official announcements have been made regarding another reverse stock split.
Whats going on with WINT? Everyone already get out of it in premarket?
50/50 positions in ADTX and WINT today. Volume on WINT about to hit 100 million and ADTX seems poised to break out at any point.
I did that’s why I’m asking you. All RS news I’m seeing is from 2023/2024. Read the last sentence. From very top answer on Google: A ccording to recent news, Windtree Therapeutics (ticker symbol: WINT) announced a reverse stock split in April 2024, with a 1-for-18 ratio, meaning for every 18 shares held, shareholders will receive 1 new share after the split takes effect; this information is current as of April 2024 and there is no indication of another reverse stock split planned for 2025 at this time.
Called WINT yesterday at .135. Super low share float and no borrowed shorts available, bout to increase my position for the day.
News reports on WINT as of an hour ago are interesting.
WINT seem to be a good play until tomorrow
While ADTX has climbed half a cent in the last hour WINT has been pumping.
WINT went parabolic 
what we thinking on WINT? alr pumped too much or got room to grow?
WINT play, about to blow https://preview.redd.it/ye8n4vz1jnie1.jpeg?width=1206&format=pjpg&auto=webp&s=3c63604e25d54f03b2ef0380c7ac6cd88838b78d
Ocea. Gonna be steady riser all day because it is actually a good company buttttttt….. we don’t want steady growth so tomorrow I think that WINT will pump really damn hard and we should buy that
$Windtree Therapeutics (WINT.US)$ loaded, lets see if tomorrow can reach 0.35-0.5. they voted for reverse split, but no exact date yet. they have until May or June to carry out the reverse split, but so far no date on it. plenty of time to squeeze!
Personally, I'm in on $WINT getting out early if it's still a 30% gain at 7am. Moving that to $ADTX if I can stay at my current entry of 0.098.
Any wild speculation on where $WINT will go? Staying stable but struggling to break through.....
WINT and HEPA watching pre-market
Got in on $WINT at .207, thoughts? Vibes?
I just got some $WINT idk we'll
Got in on that $WINT idk we’ll see 🤷🪨
I’ve been watching WINT, still early but good 5 day % change and good volume.
Besides $ADTX, also thinking about taking a position in $WINT. Good volume, decent rise...but not a super pump yet so who knows?
whoever recommended WINT, thank you! its going up
In on ADTX, WINT, holding CYN. Anyone else on WINT? Also got SDST and PEPG on the radar, anyone? nfa
Gonna be a huge day for CYN. For transparency I am now keeping an eye on WINT as a possible place to put some profits in a few days. Very low float and near its 52 week low. NFA
OCEA and CYN are set. I'm eyeing XAIR and WINT for potential entries. XAIR in particular's spike in AH interest is intriguing. WINT's 0.13 entry point with a steady increase over the last week and a significant jump to 5x volume yesterday and steady AHs could potentially prove promising.
I know people are gonna still say the obvious ones but what if tomorrow is something no one is talking about? VIRX, WINT, omga, aeon, aim
What happened to WINT? Pumped to .18 ah in like 5 mins and then dumped back to .13
Holding CYN. WINT is pumping ah it seems. Nfa
Thank you for the insight, but here’s some information in response: WINT already completed the SEISMiC trial in Phase 2, where they found the drug to successfully improve cardiac function and help patients with cardiogenic shock - something unmet in cardiovascular care. They will now proceed to the next phase and it looks very promising to eventually be released to the market. Also, yes Windtree Therapeutics (WINT) and Molecular Partners (MOA) are both biopharmaceutical companies but they are not the same. Their focuses differ significantly: Windtree Therapeutics (WINT) Focus: Acute cardiovascular care, particularly cardiogenic shock and acute heart failure. Why they are unique: their drug targets a highly specific, underserved niche in cardiovascular emergencies. So this drug will be very impactful to the market. Molecular Partners (MOA) Focus: Oncology, virology, and ophthalmology treatments using its proprietary DARPin® platform. They address diseases such as cancer, COVID-19, and retinal conditions. Key Difference: WINT is highly specialized in cardiovascular disorders, while MOA’s platform spans multiple therapeutic areas. Now I know we cannot foresee the future but everything is pointing to success due to research. I believe it’s a great time to enter and hold some shares with this low cost now, knowing that its bound to skyrocket and increase in price in time.
Gotchu! RUM: Rumble Inc. (RUM) is showing strong bullish momentum, with the current price at $6.49, significantly above its 10-day SMA of $5.84 and 20-day EMA of $5.72, indicating a robust upward trend. The RSI values are in the overbought territory, suggesting potential for a pullback, but the MACD histogram remains positive, supporting continued upward movement. Recent trading volumes have been high, reflecting increased investor interest, although today's volume is currently at zero, which could indicate a pause or consolidation phase. Given the broader market's cautious optimism and RUM's recent price action, a long position could be considered with an entry around $6.45. Set the first price target at $6.80 and a second at $7.00, with a stop loss at $6.30 to manage downside risk. Confidence in reaching the first target is moderate due to strong technical indicators, while the second target carries lower confidence given potential resistance and overbought conditions. Keep an eye on any emerging news that could impact sentiment or trading volumes. DJT: Trump Media & Technology Group Corp. (DJT) has experienced a significant rally, with its current price at $52.41, driven by the launch of its Truth+ streaming service and speculation around Donald Trump's 2024 presidential prospects. The stock's RSI values are extremely high, indicating overbought conditions, while the MACD histogram suggests strong bullish momentum. Recent trading volumes have been substantial, reflecting heightened investor interest, yet the speculative nature of the stock due to its dependency on political outcomes warrants caution. Given the broader market's cautious optimism and DJT's recent performance, a long position could be considered with an entry around $51.50. Set a first price target at $55.00 with a confidence level of 70%, and a second target at $58.00 with a 60% confidence level, given the potential for continued speculative buying. A stop loss should be placed at $48.00 to mitigate downside risk, considering the stock's volatility and external uncertainties. PPBT: Purple Biotech Ltd. (PPBT) is currently trading at $3.40, showing a significant decline from its recent highs around $5.50, indicating strong bearish momentum. The 14-day RSI is at 32.65, suggesting the stock is nearing oversold territory, but not yet signaling a reversal. The MACD histogram is slightly positive, hinting at potential short-term stabilization, but the overall trend remains negative with both SMA and EMA values above the current price. Given the lack of recent news and low trading volume compared to its 65-day average, market interest appears subdued. In the broader market context, while SPY and QQQ show resilience, PPBT's biotech sector may not benefit from this optimism due to its specific challenges. For today's session, consider entering a short position around $3.45, with a first target at $3.20 and a second target at $3.00, setting a stop loss at $3.60. Confidence in reaching the first target is moderate due to the prevailing bearish sentiment, while the second target carries lower confidence given potential support near $3.20. SVRE: SaverOne 2014 Ltd. (SVRE) is currently trading at $1.59, showing a significant decline from its recent highs, with technical indicators suggesting bearish momentum. The RSI values are below 35, indicating oversold conditions, while the MACD remains negative, reinforcing the downtrend. The stock's 10-day SMA ($2.01) and 20-day EMA ($2.18) are well above the current price, highlighting potential resistance levels. Despite the broader market's cautious optimism, SVRE's low volume and lack of recent news suggest limited buying interest. Given these factors, a short position could be considered with an entry around $1.60. Target the first price at $1.50 and a second at $1.40, with a stop loss at $1.70 to manage risk. Confidence in reaching the first target is moderate due to the oversold RSI, while the second target carries lower confidence given potential support near $1.50. WINT: Windtree Therapeutics, Inc. (WINT) is currently trading at $0.8216, showing a significant decline from its 30-day SMA of $1.5675, indicating bearish momentum. The RSI values are below 40, suggesting the stock is oversold, yet the MACD histogram is positive, hinting at potential short-term bullish divergence. However, the lack of recent news and current volume suggests limited immediate catalysts for a reversal. Given the broader market's cautious optimism and WINT's weak technical indicators, a short position could be considered. Enter at $0.82, with a first target of $0.75 and a second target of $0.70, setting a stop loss at $0.85. Confidence in reaching the first target is moderate due to oversold conditions, while the second target has lower confidence given potential support levels. Monitor for any unexpected news or volume spikes that could alter this outlook.
RUM, DJT, PPBT, SVRE, WINT, ILLR thanks man!
I am not sure about the short aspect, but current volatile stocks that may have catalysts around then include. TVGN, VNDA, HOWL and WINT TVGN new biotech. Forcast 1 billion in revenue 18-22 billion over 5 years. They are already 600% up on the month. 300% since I first bought after their forecast. When they report earnings, things could go boom boom. VNDA - They rejected a second takeover bid valued at 8 dollars a share. The stock popped, but is down again and you may find a good price. There must be a reason that insiders think the company is undervalued at 8 dollars a share. HOWL has 2 poster presentations coming up in early November. The stock had been quite volatile since the announcement and is currently up 50%. WINT - They have similar presentations coming up on recent positive study data and meetings with investors at a conference on October 30th.
WINT shredded in value after the leadership change
WINT, multiple drugs in trials full financing and a billion dollars in potential proceeds as well as millions in royalties. It's been shorted for months and currently has a float of 1.5 million and a market cap of less than 2 million. Extremely undervalued.
**Top pre-market gainers:** $LIPO +226% $NLSP +71% $YIBO +45% $PALI +41% $TIVC +24% **Top pre-market losers:** $NAMS -25% $CERO -23% $IART -22% $WINT -21% LUXH -17%
**Pre-Market Gainers:** $WINT +151% $CREV +76% $BFI +63% $EVRI +41% $RGC +34% **Pre-Market Losers:** $NBY -57% $NMHI -46% $TANH -45% $DXCM -37% $POAI -24%
WINT. Their drug is legit, if they can get off their asses and get phase 3 trials completed
I do like WINT, even more after the release they put out yesterday re: working with an advisor. They have never referenced a potential buyout before, and there's no way they get bought out for less than many multiples of the current SP if that comes.
Are you still high on WINT? Do you think we will see an increase when quarterly earnings drop?
WINT and ICU are my plays going into next week.
WINT is my bio play of the year. Their drug for advanced heart failure will have phase 3 results later in 2024 and i predict a 10-20x from current price
**WINT** is about to run IMO - the good news from this week (below) isn't priced in at all yet because their ATM looks like it just finished so it's finally ready to take off. DYODD. [https://finance.yahoo.com/news/138-million-milestones-low-double-140000145.html](https://finance.yahoo.com/news/138-million-milestones-low-double-140000145.html)
My issue with ICU is that every approval is for the same device - it's rinse and repeat news. Unless I'm missing something further, I don't see how repetitive approvals for the same device move the needle here, especially considering three approvals have already come and gone and the stock isn't any better for them. For WINT, recommend checking out this update they shared last year re: their leading candidate - they're going to enter Phase 3 with it domestically this summer, but are accelerated to Phase 3 in China because of the deal they just closed with Lee: [https://finance.yahoo.com/news/windtree-therapeutics-announces-publication-seismic-120000969.html](https://finance.yahoo.com/news/windtree-therapeutics-announces-publication-seismic-120000969.html)
It looks like with WINT, the treatment still is being developed? Seems like more of a long shot. In one of the recent PR reports with ICU, they already received a "confirmation letter" of commercialization from the FDA stating that they have everything they need to approve them they just have to redo the labelling and one other thing I forgot. (Tiny things, not related to product itself.) Also, cause ICU got breakthrough device designation, they are actively working with the FDA directly to make these tiny adjustments. (Talking about the labelling issue I mentioned above.) So, from what I understand, ICU approval is imminent/pending already. It isn't unsure. So, once ICU pediatric device gets approved for commercialization, it will essentially mean that their adult version of the product will be approved too. (The adult version is just a larger version of the kids version I believe, and, it shows just as good results from what I've read on their presentations/PR's.) Well, let me know your thoughts about my little rant here. \^\^ Maybe I am missing something/
**WINT** is cheaper than **ICU** (which I know has a fan club here) and has a pipeline of 2024 candidates that blow it out of the water. It also just received a deal worth up to **$138M** and currently has a market cap of only **$2.3M**: [https://finance.yahoo.com/news/138-million-milestones-low-double-140000145.html](https://finance.yahoo.com/news/138-million-milestones-low-double-140000145.html)
I got in at 1.15 and had a ball with it I’m in $WINT and $WHLR Lots of folks saying $WHLR will expload on Thursday and Friday and $WINT is the long term but it’s got allot of promise and low float so it could jump like crazy upon good news I too feel for the TCBP crAze and lost a good bit but made it all up on RDHL
Take a look at $WINT they have been showing nice volume lately and have a super promising cardiac drug. They are prime for a buyout.
WINT volume is rising and phase 3 announcements should be coming early fall. The time to get in is now
Yeah, i saw one DD from WINT 2 months ago. I did some and manage to buy at 1.20 and sell at 1.50. But since 07/20 theres like no volume, nothing move, low downtrend but looks like a lot of buying at 1.3$ level
Yeah for sure. People will downvote all they want because they like to overhold stocks for too long. But i bought ttoo at .10 and sold 80000 shares at .36, imux 1.45 and sold 2.90, and now I’m eyeing WINT as the next mover. It will hover between 1.30-1.50 until they announce the next trial commencement and it’ll pump into the mid 2’s. People in this subreddit aren’t interested in doing real DD